TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype

Springer Science and Business Media LLC - Tập 122 Số 6 - Trang 703-713 - 2011
Yvonne Davidson1, Samantha Raby2, Penelope G. Foulds2, Andrew C Robinson1, James C. Thompson3,1, Stephen Sikkink4, Imran H. Yusuf1, Hanan Amin1, Daniel DuPlessis1, Claire Troakes5, Safa Al‐Sarraj5, Carolyn Sloan6, Margaret M. Esiri6, V. P. Prasher7,8, David Allsop2, David Neary3, Stuart Pickering‐Brown4, Julie S. Snowden3, David Mann1
1Mental Health and Neurodegeneration Research Group, Faculty of Medical and Human Sciences, Salford Royal Foundation Trust, University of Manchester, Salford, UK
2Division of Biomedical and Life Sciences, School of Health and Medicine, University of Lancaster, Lancaster, UK
3Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal Foundation Trust, Hope Hospital, Salford, UK
4Mental Health and Neurodegeneration Research Group, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
5London Neurodegenerative Diseases Brain Bank, Department of Clinical Neuroscience, Institute of Psychiatry, King’s College London, London, UK
6Neuropathology Department, John Radcliffe Infirmary, University of Oxford, Oxford, UK
7Liverpool John Moores University, Liverpool, UK
8South Birmingham Community NHS Trust, Birmingham, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Amador-Ortiz C, Lin W-L, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445

Arai T, Mackenzie IRA, Hasegawa M, Nonaka T, Niizato K, Tsuchiya K, Iritani S, Onaya M, Akiyama H (2009) Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies. Acta Neuropathol 117:125–136

Baborie A, Griffiths TD, Jaros E, Richardson A, Ferrari R, Moreno J, Momeni P, McKeith IG, Burn DJ, Duplessis D, Pal P, Rollinson S, Pickering-Brown SM, Thompson JC, Neary D, Snowden JS, Perry R, Mann DMA (2011) Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol 121:365–373

Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R (2002) Relative frequencies of Alzheimer disease, Lewy body disease, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida Brain Bank. Alzheimer Dis Assoc Disord 16:203–212

Bigio EH (2011) TDP-43 variants of Frontotemporal lobar degeneration. J Mol Neurosci (in press)

Bigio EH, Mishra M, Hatanpaa KJ, White CL III, Johnson N, Rademaker A, Weitner BB, Deng H-X, Dubner SD, Weintraub S, Mesulam M (2010) TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol 120:43–54

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-type pathological changes. Acta Neuropathol 82:239–259

Buratti E, Brindisi A, Pagini F, Baralle FE (2004) Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 74:1322–1325

Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV (2006) Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol 60:677–687

Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB (2000) The relative frequency of ‘dementia of unknown etiology’ increases with age and is nearly 50% in nonagenerarians. Arch Neurol 57:713–719

Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown SM, Du Plessis D, Neary D, Snowden JS, Mann DMA (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521–533

Dickson DW, Davies P, Bevona C, Van Hoeven FH, Factor SM, Grober E, Aronson MK, Crystal HA (1994) Hippocampal sclerosis: a common pathological feature in very old (> or = 80 years of age) humans. Acta Neuropathol 88:212–221

Farrer MJ, Hulihan MM, Kachergus JM, Dachsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilarino-Guell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK (2009) DCTN1 mutations in Perry syndrome. Nat Genet 41:163–165

Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical clinical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498

Geser F, Winton MJ, Kwong LW, Xu Y, Igaz LM, Garruto RM, Perl DP, Galasko D, M-Y Lee V, Trojanowski JQ (2008) Pathological TDP-43 in parkinsonism dementia complex and amyotrophic lateral sclerosis. Acta Neuropathol 115:133–146

Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, Moberg PJ, Moore EK, Van Deerlin VM, Lee VM-Y, Arnold SE, Trojanowski JQ (2010) Pathological 43-kDa transactivation response DNA-binding protein in older adult with and without severe mental illness. Arch Neurol 67:1238–1250

Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T, Yamazaki M, Oyanagi K (2007) TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130:1386–1394

Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, Petersen RC, Parisi JE (2008) Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer’s disease. Acta Neuropathol 116:215–220

Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker N, Rademakers R, Boeve BF, Parisi JE, Smith GE, Ivnik RJ, Petersen RC, Jack CR, Dickson DW (2008) Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70:1850–1857

Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122:137–154

Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K (2009) Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relationship to AD common pathology. Neuropathology 29:566–573

King A, Sweeney F, Bodi I, Troakes C, Maekawa S, Al-Sarraj S (2010) Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system in high and moderate stages of Alzheimer’s disease. Neuropathology 30:408–419

Leverenz JB, Agustin CM, Tsuang D, Peskind ER, Edland SD, Nochlin D, DiGiacano L, Bowen JD, McCormick WC, Teri L, Raskind MA, Kukull WA, Larson EB (2002) Clinical and neuropathological characteristics of hippocampal sclerosis. A community based study. Arch Neurol 59:1099–1106

Lippa CF, Rosso AL, Stutzbach LD, Neumann M, Lee VM-Y, Trojanowski JQ (2009) Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch Neurol 66:1483–1488

Mackenzie IR, Rademakers R, Neumann M (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and Frontotemporal dementia. Lancet Neurol 10:995–1007

Mann DMA (1988) Alzheimer’s disease and Down’s syndrome. Histopathology 13:125–138

McKhann G, Drachman D, Folstein M (1984) Clinical diagnosis of Alzheimer’s disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944

Mirra SS, Heyman A, McKeel D (1991) The consortium to establish a registry for Alzheimer’s disease Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486

Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine JB, Lee VM-Y, Trojanowski JQ (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114:221–229

Nelson PT, Scmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodward JL, Van Eldik LJ, Krysio RJ (2011) Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 134:1506–1518

Petrovich H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, Nelson J, Hardman J, Curb JD, Blanchette PL, Launer LJ, Yano K, Markesbery WR (2005) AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 57:98–103

Snowden JS, Stopford CL, Julien CL, Thompson JC, Davidson Y, Gibbons L, Pritchard A, Lendon CL, Richardson AM, Varma A, Neary D, Mann DMA (2007) Cognitive phenotypes in Alzheimer’s disease and genetic risk. Cortex 43:835–845

Stopford CL, Snowden JS, Thompson JC, Neary D (2008) Variability in cognitive presentation of Alzheimer’s disease. Cortex 44:185–195

Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM-Y, Trojanowski JQ, Neumann M (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555–564

Wang HY, Wang IF, Bose J, Shen CK (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83:130–139

Yokota O, Davidson Y, Arai T, Hasegawa M, Akiyama H, Ishizu H, Terada S, Sikkink S, Pickering-Brown S, Mann DMA (2010) Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease. Acta Neuropathol 120:789–801

Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DMA (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55–66

Zarow C, Sitzer TE, Chui HC (2008) Understanding hippocampal sclerosis in the elderly: epidemiology, characterisation and diagnostic issues. Curr Neurol Neurosci Rep 8:363–370